Paper318924
The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice.
Connor TH and 3 others. Cancer Res, 1977. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice. Papers, record 318924. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/318924
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metronidazole | Major topic |
| Mutagens | Major topic |
| Animals | |
| Carbon Tetrachloride | |
| Humans | |
| In Vitro Techniques | |
| Liver | |
| Mice | |
| Mutation | |
| Salmonella typhimurium |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37335844 | Antimicrobial Transformation Products in the Aquatic Environment: Global Occurrence, Ecotoxicological Risks, and Potential of Antibiotic Resistance. | Environ Sci Technol | 2023 | https://conductscience.org/library/papers/37335844 | PubMed |
| 36211197 | Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip® assay in TK6 cells. | Front Toxicol | 2022 | https://conductscience.org/library/papers/36211197 | PubMed |
| 29170735 | A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests. | Front Public Health | 2017 | https://conductscience.org/library/papers/29170735 | PubMed |
| 28209207 | Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis. | Parasit Vectors | 2017 | https://conductscience.org/library/papers/28209207 | PubMed |
| 25319099 | Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa. | Pharm Res | 2015 | https://conductscience.org/library/papers/25319099 | PubMed |
| 24619489 | In vitro efficacy of curcumin on Trichomonas vaginalis. | Wien Klin Wochenschr | 2014 | https://conductscience.org/library/papers/24619489 | PubMed |
| 20981287 | Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole. | J Parasitol Res | 2009 | https://conductscience.org/library/papers/20981287 | PubMed |
| 17962782 | Solid phase synthesis of a metronidazole oligonucleotide conjugate. | Molecules | 2006 | https://conductscience.org/library/papers/17962782 | PubMed |
| 17223627 | Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites. | Clin Microbiol Rev | 2007 | https://conductscience.org/library/papers/17223627 | PubMed |
| 15489348 | Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. | Clin Microbiol Rev | 2004 | https://conductscience.org/library/papers/15489348 | PubMed |
| 7009387 | Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells. | Hum Genet | 1980 | https://conductscience.org/library/papers/7009387 | PubMed |
| 6757140 | Mutagens in urine of carbon electrode workers. | Int Arch Occup Environ Health | 1982 | https://conductscience.org/library/papers/6757140 | PubMed |
| 3830698 | Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. | Environ Health Perspect | 1985 | https://conductscience.org/library/papers/3830698 | PubMed |
| 3757951 | Urine mutagenicity as an indicator of exposure to dietary mutagens formed during cooking of foods. | Environ Health Perspect | 1986 | https://conductscience.org/library/papers/3757951 | PubMed |
| 708572 | Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole. | Br J Cancer | 1978 | https://conductscience.org/library/papers/708572 | PubMed |
| 565299 | Mammalian spot test with moxnidazole, a 5-nitroimidazole. | Experientia | 1978 | https://conductscience.org/library/papers/565299 | PubMed |
| 508562 | Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. | Br J Cancer | 1979 | https://conductscience.org/library/papers/508562 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/318924
GET https://conductscience.org/api/papers/v1/318924/authors